Patents Assigned to EIP PHARMA, LLC
  • TREATMENT OF A SELECTIVE POPULATION OF PATIENTS HAVING DEMENTIA WITH LEWY BODIES
    Publication number: 20250387399
    Abstract: The present invention provides methods and compositions for the treatment of subjects that have Dementia with Lewy Bodies (DLB) but have no substantial tau pathology. Subjects with DLB that have no substantial tau pathology are shown to be particularly responsive to treatment with a selective p38? mitogen activated protein kinase (MAPK) inhibitor compared to subjects with DLB that have substantial tau pathology.
    Type: Application
    Filed: August 28, 2025
    Publication date: December 25, 2025
    Applicant: EIP Pharma, LLC
    Inventor: John Jahangir Alam
  • TREATMENT OF A SELECTIVE POPULATION OF PATIENTS HAVING DEMENTIA WITH LEWY BODIES
    Publication number: 20250339435
    Abstract: The present invention provides methods and compositions for the treatment of subjects that have Dementia with Lewy Bodies (DLB) but have no substantial tau pathology. Subjects with DLB that have no substantial tau pathology are shown to be particularly responsive to treatment with a selective p38? mitogen activated protein kinase (MAPK) inhibitor compared to subjects with DLB that have substantial tau pathology.
    Type: Application
    Filed: November 4, 2022
    Publication date: November 6, 2025
    Applicant: EIP Pharma, LLC
    Inventor: John Jahangir Alam
  • Co-crystals of neflamapimod (VX-745)
    Patent number: 11466008
    Abstract: Provided herein are co-crystal forms comprising 5-(2,6-dichlorophenyl)-2-(2,4-difluorophenylthio)-6H-pyrimido[1,6-b]pyridazin-6-one (VX-745): and compositions thereof, useful as inhibitors of one or more protein kinases and which exhibit desirable characteristics for the same.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: October 11, 2022
    Assignee: EIP Pharma, LLC
    Inventors: John Jahangir Alam, Jeffrey Douglas Wilson
  • CO-CRYSTALS OF NEFLAMAPIMOD (VX-745)
    Publication number: 20200308176
    Abstract: Provided herein are co-crystal forms, and compositions thereof, useful as inhibitors of one or more protein kinases and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: September 18, 2018
    Publication date: October 1, 2020
    Applicant: EIP Pharma, LLC
    Inventors: John Jahangir Alam, Jeff Wilson
  • Pharmaceutical formulations of neflamapimod
    Patent number: 10653695
    Abstract: Disclosed are oral pharmaceutical compositions of neflamapimod that exhibit suitable exposure for administration in humans and/or that maintain a desirable dissolution profile under standard storage conditions.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: May 19, 2020
    Assignee: EIP Pharma, LLC
    Inventors: John Jahangir Alam, Jeffrey Douglas Wilson
  • COMPOSITIONS AND METHODS FOR TREATING DEMENTIA
    Publication number: 20190381049
    Abstract: The present invention provides methods and compositions for improving episodic memory and treating dementia.
    Type: Application
    Filed: August 23, 2019
    Publication date: December 19, 2019
    Applicant: EIP Pharma, LLC
    Inventor: John Jahangir Alam
  • Compositions and methods for treating dementia
    Patent number: 10420770
    Abstract: The present invention provides methods and compositions for improving episodic memory and treating dementia.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: September 24, 2019
    Assignee: EIP Pharma, LLC
    Inventor: John Jahangir Alam
  • Methods for treating neurologic disorders
    Patent number: 9579322
    Abstract: The present invention provides methods for treating a neurological disorder.
    Type: Grant
    Filed: July 8, 2015
    Date of Patent: February 28, 2017
    Assignee: EIP Pharma, LLC
    Inventor: John Jahangir Alam
  • Methods and compositions for recovery from stroke
    Patent number: 9427439
    Abstract: The present invention provides methods and compositions for promoting recovery of function from neurologic injury, such as ischemic injury caused by acute stroke.
    Type: Grant
    Filed: October 26, 2015
    Date of Patent: August 30, 2016
    Assignee: EIP Pharma, LLC
    Inventor: John Jahangir Alam
  • Compositions and methods for treating Alzheimer's disease
    Patent number: 9427438
    Abstract: The present invention provides compositions for reducing amyloid plaque burden associated with Alzheimer's disease and methods of using the same.
    Type: Grant
    Filed: September 15, 2015
    Date of Patent: August 30, 2016
    Assignee: EIP Pharma, LLC
    Inventor: John Jahangir Alam
  • COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE
    Publication number: 20140357638
    Abstract: The present invention provides compositions for reducing amyloid plaque burden associated with Alzheimer's disease and methods of using the same.
    Type: Application
    Filed: February 27, 2014
    Publication date: December 4, 2014
    Applicant: EIP Pharma, LLC
    Inventor: John Jahangir Alam
  • Compositions and methods for treating alzheimer's disease
    Patent number: 8697627
    Abstract: The present invention provides compositions for reducing amyloid plaque burden associated with Alzheimer's disease and methods of using the same.
    Type: Grant
    Filed: May 9, 2012
    Date of Patent: April 15, 2014
    Assignee: EIP Pharma, LLC
    Inventor: John Jahangir Alam
  • COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE
    Publication number: 20120289511
    Abstract: The present invention provides compositions for reducing amyloid plaque burden associated with Alzheimer's disease and methods of using the same.
    Type: Application
    Filed: May 9, 2012
    Publication date: November 15, 2012
    Applicant: EIP PHARMA, LLC
    Inventor: John Jahangir Alam